Pharmaceuticals, Biotechnology and Life Sciences
Company announcement – No. 2 / 2021 Zealand Pharma major shareholder announcement: The Capital Group Companies, January 2022 Copenhagen, DK and…
COVID-19 patients with newly diagnosed SARS-CoV-2 infections were treated in these randomized, double-blind, placebo-controlled Phase 2 trials in the US and…
OT-101 is Oncotelic’s RNA Therapeutic Against TGF-βOT-101 has completed over six clinical trials against solid tumors with good efficacyOT-101 is…
Company honored for commitment to improve gender representation across ranks and promote women to leadership roles BOSTON, and DURHAM, N.C.,…
Accomplished academic and industry veteran with a successful record developing treatments for B cell lymphomaAURORA, Colo., Jan. 19, 2022 (GLOBE…
Q2 momentum sets the stage for a strong FY22MELBOURNE, Australia, Jan. 19, 2022 (GLOBE NEWSWIRE) — Genetic Technologies Limited (ASX:…
Phase 1/2 ABILITY study of MDNA11 remains on track for an update on additional safety pharmacokinetic (PK), and pharmacodynamic (PD)…
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code…
BURLINGAME, Calif., Jan. 13, 2022 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals, Inc. (Corvus or the Company) (NASDAQ: CRVS), a clinical-stage biopharmaceutical…
PRINCETON, N.J., Jan. 12, 2022 (GLOBE NEWSWIRE) — On January 10, 2022, the tri-agencies, Department of Labor (DOL), Health and…